Scarica l'app Stockscreener
86.66
1.03%
-0.90
Dopo l'orario di chiusura:
86.36
-0.30
-0.35%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$87.56
Aprire:
$88
Volume 24 ore:
689.50K
Relative Volume:
0.75
Capitalizzazione di mercato:
$3.00B
Reddito:
$635.89M
Utile/perdita netta:
$171.92M
Rapporto P/E:
19.89
EPS:
4.357
Flusso di cassa netto:
$151.36M
1 W Prestazione:
+1.90%
1M Prestazione:
-1.91%
6M Prestazione:
-30.52%
1 anno Prestazione:
-27.67%
Intervallo 1D:
$85.47
$89.41
Intervallo di 1 settimana:
$79.23
$90.67
Portata 52W:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
86.66 | 2.85B | 635.89M | 171.92M | 151.36M | 4.357 |
ABT
Abbott Laboratories
|
102.23 | 176.41B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.77 | 116.35B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
280.13 | 105.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.55 | 62.29B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.25 | 48.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Aggiornamento | Needham | Hold → Buy |
| 2025-10-13 | Iniziato | Jefferies | Buy |
| 2025-09-16 | Iniziato | Evercore ISI | Outperform |
| 2025-09-04 | Iniziato | Stifel | Hold |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
(TMDX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Is TransMedics Group Inc (TMDX) a Bargain After 3.4% Drop? GF Value Says Undervalued - GuruFocus
TransMedics Slides After CFO Transition News Despite Reaffirmed 2026 Outlook - Quiver Quantitative
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.1%What's Next? - MarketBeat
Needham reiterates Buy on TransMedics stock, names new CFO By Investing.com - Investing.com UK
TransMedics appoints Fernando Araujo as CFO to drive growth, reiterates 2026 revenue guidance of $737-$757M. - Pluang
TransMedics Appoints Fernando Araujo as CFO with Detailed Compensation and Transition Plan - Kalkine Media
TransMedics names Fernando Araujo as CFO, reaffirms 2026 outlook By Investing.com - Investing.com India
(TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M$757M, vs. FactSet Est of $743.1M - marketscreener.com
TransMedics Group, Inc. Reiterates Revenue Guidance for the Full Year 2026 - marketscreener.com
TransMedics Group (NASDAQ:TMDX): Is the Market Too Cautious? - Kalkine Media
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
NFLX: Netflix Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
TMDX Stock Rallies As Analyst Sees 77% Upside — Here’s Why - Stocktwits
TransMedics Group (TMDX) Institutional Ownership 2026 - MarketBeat
TMDX Reiterated by TD Cowen -- Price Target Maintained at $120 - GuruFocus
TransMedics Group's (TMDX) "Buy" Rating Reiterated at TD Cowen - MarketBeat
TransMedics: Slowing Growth Brings Its Valuation Into Question (NASDAQ:TMDX) - Seeking Alpha
Law firm probes TransMedics officers for possib... - pluang.com
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - The Conway Daily Sun
TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Buy Ratings and 8.14% Upside Potential - DirectorsTalk Interviews
TransMedics Group (TMDX) Stock Price, News & Analysis - MarketBeat
Jupiter Topco LLC Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat
The Manufacturers Life Insurance Company Acquires Shares of 17,159 TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group, Inc. $TMDX Position Increased by FirstWave Capital Management LLC - MarketBeat
19,289 Shares in TransMedics Group, Inc. $TMDX Bought by Corient Private Wealth LP - MarketBeat
Legal & General Group Plc Invests $5.29 Million in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group, Inc. $TMDX Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Is TransMedics Group (TMDX) Undervalued Following Its Earnings Miss And Margin Guidance Cut? - simplywall.st
TransMedics Group Inc (TMDX) Shares Surge 3.2% -- What GF Score of 69 Tells Investors - GuruFocus
Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure? - Yahoo Finance
Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report? - Yahoo Finance
Braidwell LP Has $40.50 Million Position in TransMedics Group, Inc. $TMDX - MarketBeat
(TMDX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
TransMedics Group, Inc. Investor News: Rosen Law Firm - GlobeNewswire
Empowered Funds LLC Purchases New Stake in TransMedics Group, Inc. $TMDX - MarketBeat
193,752 Shares in TransMedics Group, Inc. $TMDX Purchased by Bank of New York Mellon Corp - MarketBeat
Headlands Technologies LLC Purchases Shares of 24,599 TransMedics Group, Inc. $TMDX - marketbeat.com
Rosen Law investigates TransMedics Group for po... - Pluang
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc.TMDX - PR Newswire
Is TransMedics Group Inc (TMDX) a Bargain After 4.0% Drop? GF Va - GuruFocus
TransMedics Group Drops 5.7% Amid Sector-Wide Selling - AlphaStreet
TransMedics to present at two major healthcare investor conferences in September 2026 - Pluang
TransMedics to Present at Upcoming September Investor Conferences - PR Newswire
TransMedics Group (NASDAQ:TMDX) Trading Down 5.5%Time to Sell? - MarketBeat
TransMedics Group, Inc. (TMDX) Investor Outlook: Harnessing a 10% Upside Potential in Medical Devices - DirectorsTalk Interviews
TransMedics Group, Inc. $TMDX Shares Sold by Beaconlight Capital LLC - MarketBeat
TransMedics plans two New York investor talks on Sept. 14 and 15 - Stock Titan
Algert Global LLC Purchases 31,710 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc.TMDX - PR Newswire
EP Wealth Advisors LLC Purchases Shares of 15,401 TransMedics Group, Inc. $TMDX - MarketBeat
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Transmedics Group Inc Azioni (TMDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Option Exercise |
2.21 |
19,285 |
42,620 |
26,266 |
| Gunderson Thomas J. | Director |
Jun 15 '26 |
Sale |
75.06 |
9,624 |
722,377 |
16,642 |
2.61%
1.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):